EAGLE PHARMACEUTICALS, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2023.

Symbol
EGRX on OTC
Location
Woodcliff Lake, NJ
Fiscal year end
31 December
Latest financial report
09 Aug 2023

Quick Takeaways

  • EGRX - EAGLE PHARMACEUTICALS, INC. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2023.
  • Headline metric: Return On Equity 4.9%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-54%</span>.
  • Most recent SEC facts end date: 01 Aug 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2023-08-01) highlights Return On Equity 4.9%, Return On Assets 3.0%, and Operating Margin 15.9%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

40.5/100

Caution Confidence high

Return On Equity

4.9%

Metric score 0.0/100

Return On Assets

3%

Metric score 13.0/100

Financial Health

Current Ratio
2.16x
Quick Ratio
1.51x
Debt to Equity
0.68x

Strengths

Current Ratio, Quick Ratio, and Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Revenues YoY

Key metrics snapshot

Return On Equity

4.9%

YoY: -54%

Industry median: -43% (n=675)

View history

Return On Assets

3%

YoY: -57%

Industry median: -47% (n=673)

View history

Operating Margin

16%

YoY: -25%

Industry median: -121% (n=298)

View history

Current Ratio

2.16x

YoY: +21%

Industry median: 3.39x (n=667)

View history

Quick Ratio

1.51x

YoY: +34%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.68x

YoY: +40%

Industry median: 0.26x (n=530)

View history

Revenues YoY

-5.4%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

-48%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity 4.9% -54%
Return On Assets 3% -57%
Operating Margin 16% -25%

Financial Health

Metric Latest value YoY change
Current Ratio 2.16x +21%
Quick Ratio 1.51x +34%
Debt-to-equity 0.68x +40%

Growth

Metric Latest value YoY change
Revenues YoY -5.4%
NetIncomeLoss YoY -48%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 12,986,971 -2.2%
Common Stock, Value, Issued $18,000 0%
Weighted Average Number of Shares Outstanding, Basic 13,090,852 +2%
Weighted Average Number of Shares Outstanding, Diluted 13,154,599 +2.5%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $257,551,000 -5.4%
Research and Development Expense $35,648,000 -20%
Costs and Expenses $216,546,000 +0.99%
Operating Income (Loss) $41,005,000 -29%
Nonoperating Income (Expense) $11,835,000 +32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $29,170,000 -28%
Income Tax Expense (Benefit) $17,222,000 -2%
Earnings Per Share, Basic 1 -53%
Earnings Per Share, Diluted 1 -50%
Cash and Cash Equivalents, at Carrying Value $15,354,000 -58%
Accounts Receivable, after Allowance for Credit Loss, Current $115,140,000 +34%
Inventory, Net $42,482,000 -26%
Other Assets, Current $3,820,000 +32%
Assets, Current $187,250,000 -3.7%
Deferred Income Tax Assets, Net $30,715,000 +32%
Property, Plant and Equipment, Net $1,013,000 -31%
Intangible Assets, Net (Excluding Goodwill) $107,406,000 -4.5%
Goodwill $45,033,000 +4.6%
Other Assets, Noncurrent $33,405,000 +373%
Assets $404,822,000 +6%
Accounts Payable, Current $15,843,000 -21%
Liabilities, Current $86,630,000 -20%
Operating Lease, Liability, Noncurrent $839,000 -63%
Other Liabilities, Noncurrent $4,256,000 +89%
Liabilities $152,782,000 +6.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,112,000 -149%
Retained Earnings (Accumulated Deficit) $122,418,000 +11%
Stockholders' Equity Attributable to Parent $252,040,000 +5.9%
Liabilities and Equity $404,822,000 +6%
Common Stock, Shares Authorized 50,000,000 0%
Common Stock, Shares, Issued 17,647,390 +0.56%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,354,000 -58%
Operating Lease, Liability $2,261,000 -39%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $8,555,000 -67%
Lessee, Operating Lease, Liability, to be Paid $2,374,000 -41%
Property, Plant and Equipment, Gross $7,834,000 +0.95%
Operating Lease, Liability, Current $1,422,000 -3.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $413,000 -63%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,122,000 -33%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 -100%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 1,500,000 0%
Unrecognized Tax Benefits $0
Additional Paid in Capital $373,831,000 +4.3%
Preferred Stock, Shares Outstanding 0
Amortization of Intangible Assets $19,997,000 +423%
Depreciation, Depletion and Amortization $446,000 -42%
Share-based Payment Arrangement, Expense $16,487,000 -6.1%
Interest Expense $6,091,000 +256%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY